about
A Review of Nanoliposomal Delivery System for Stabilization of Bioactive Omega-3 Fatty AcidsConcentration dependence of nitroxyl spin probes in liposomal solution: electron spin resonance and overhauser-enhanced magnetic resonance studies.Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study.Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.Filter-extruded liposomes revisited: a study into size distributions and morphologies in relation to lipid-composition and process parameters.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Ocular delivery systems for topical application of anti-infective agents.Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.Determination of the size distribution of liposomes by SEC fractionation, and PCS analysis and enzymatic assay of lipid content.Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Pharmacokinetics and tissue distribution of liposomal etoposide in rats.The Diverse Range of Possible Cell Membrane Interactions with Substrates: Drug Delivery, Interfaces and Mobility.Serum pharmacokinetics of choline, trimethylamine, and trimethylamine-N-oxide after oral gavage of phosphatidylcholines with different fatty acid compositions in mice.Chitosan-coated liposomes encapsulating curcumin: study of lipid–polysaccharide interactions and nanovesicle behavior
P2860
Q26767211-2CD94502-B186-400F-BE0D-EB6BC62BF005Q31145057-1B3DD80E-2339-4972-9F2F-67323E0391C0Q33553453-FFEA28FB-6DAC-4A3B-9760-150E3AA20E65Q35092346-153BD4F5-7E70-4F88-BD95-A9183CA21C33Q35127147-515B8971-A551-47F4-8039-13B9CA88D1F9Q35590884-C881DC39-AC68-40CD-AD55-DE62FCE56E38Q37938830-B04159F4-1AF2-492B-99B1-F9C9D68991B5Q38577846-A2E51A05-F0BC-4EEC-BA6C-3698243A9777Q39508657-2C8C9E83-E87D-48C3-B575-FB02E29CAF3AQ42051734-46E94B33-6266-4AC8-9643-76997782603DQ42339249-3E2CE187-5C29-485D-B12C-A1B0B4DE973CQ43259047-899F0D23-34D6-4EA9-A45B-EA01BCEE8D4AQ47302175-162F3882-2FCF-4E29-B631-77E11F4EDACEQ51251838-7D99E33B-FB8A-42BD-8616-6F9DDA421572Q57573271-CDFF3A60-D2EB-4B65-B25A-1CC90AD3B273
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Liposomes as drug carriers: a technological approach.
@ast
Liposomes as drug carriers: a technological approach.
@en
Liposomes as drug carriers: a technological approach.
@nl
type
label
Liposomes as drug carriers: a technological approach.
@ast
Liposomes as drug carriers: a technological approach.
@en
Liposomes as drug carriers: a technological approach.
@nl
prefLabel
Liposomes as drug carriers: a technological approach.
@ast
Liposomes as drug carriers: a technological approach.
@en
Liposomes as drug carriers: a technological approach.
@nl
P1476
Liposomes as drug carriers: a technological approach.
@en
P2093
P356
10.1016/S1387-2656(01)07033-8
P577
2001-01-01T00:00:00Z